Guest View
User: Pass: | become a member
Sign up here for a 30-day FREE trial of our PSW Report! (NO Credit Card required.) Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

View Single Comment

 
phil

Good morning!

Things are looking up so far (so that's my prediction, StJ – 8) ) as Turkey jackboots their way to stability.  

The Nikkie popped a lovely 300 points over 13,200 (oops, so I guess I already did say up at 4:09) despite the fact that the Yen barely made 97 before getting pushback (now  96.63).  The Dollar's at 81.43 and the Euro couldn't hold $1.33 (now $1.328) but the Pound is way up at $1.567 so could go either way on the Buck.  I'd take the money and run on /NKD if you haven't already (+$1,500) as I think this is it for the pre-market run (goes for all indices).  

Oil is $95.44 and can't get over $95.50 so far (a line we can play short on /CL), gold is $1,376 despite the sheeple being stampeded out of stocks by the WSJ:

[image]

Silver hit $21.28 but failed there, copper with a big move from $3.17 to $3.23 but now $3.22 , nat gas going nowhere are $3.72 and gasoline being kept around $2.815 for as long as they can.  Meanwhile, the FT becomes the first publication to finally realize the VELOCITY of money is what's killing us (my first day lecture at the AC Conference), not the supply:

Want proof that monetary policy has reached the limits of its effectiveness? Look no further than the money multiplier, says BofA, whose research team amusingly notes that at 0.8, the M1 multiplier is "really a divisor." With the relevance of monetarist channels in decline, "it's all about fiscal policy now," says FT's Izabella Kaminska. 

The channel through which money creation is expected to stimulate the economy is credit creation. However, not only has the money multiplier process broken down, but the linkages from money growth to credit growth are at best very limited, as Chart 2 reveals. Since the end of the Volcker disinflation, the correlation between year-on-year growth of M2 and credit (measured here as loans and leases by banks) is just 0.13%. Bank lending arguable is soft now relative to historical trends because both loan supply and demand are restrained — albeit gradually improving. High lending standards and regulatory uncertainty hold back supply, while slow growth, deleveraging and depressed collateral values keep demand low.

You can print infinite amounts of money but the practice of then giving that money to Banksters and the top 1% who use it only to create more wealth for themselves and don't "trickle down" to the bottom 90% gives you infinity times zero and your economy still sucks.  Only when money makes it to the bottom 80% through job growth (300,000 – 400,000 a month, not 175,000, which barely keeps up with population growth), building and wage inflation can you have an expanding economy.  Finally the FT gets it – let's hope some of our "leaders" begin to as well. 

Same goes for Japan:

Although the chances are good that "the current economic upswing [will] gather further pace" in Japan, policies designed to alter demographic trends and boost the labor force participation rate are "unlikely to have a significant impact on economic growth," Credit Suisse says. As for boosting inflation, "there are a number of reasons to doubt that the BOJ … will achieve its target." The good news: Fears that inflation expectations combined with institutional selling could trigger a government bond (JGBLJGBTJGBSJGBD) crisis are "probably exaggerated." 

If all we do this morning is test 15,200 from the bottom on the Dow and 9,280 on the NYSE (weak bounce lines) and then fail those – that's going to be bearish so we'll key off those moves early on.  

Wednesday's economic calendar:
7:00 MBA Mortgage Applications
10:30 EIA Petroleum Inventories
1:00 PM Results of $21B, 10-Year Bond Auction
2:00 PM Treasury Budget
 

Japanese shares (EWJ) have had another volatile day, falling as much as 2.4% before rebounding to close a mere -0.2%. European stocks (FEZ) have recovered a bit of poise after two days of declines, as has the dollar-yen rate (FXY), which is +0.75%. But the continuing theme of uncertainty about central bank stimulus is keeping markets on edge. Hong Kong and China closed. India -0.2%. EU Stoxx 50 +0.2%, London flat, Paris +0.2%, Frankfurt +0.1%, Madrid+0.65%, Milan +0.1%.

Japan's core machinery orders fell for the first month in three in April, dropping 8.8% on month vs +14.2% in March and consensus of -8.5%. On year, orders -1.1% vs +2.4% and -4.8%. The figures, which are a leading but volatile indicator of capex, show that companies are still reluctant to spend despite the government's and BOJ's stimulus policies. (PR)

The U.K.'s market supervisor, the Financial Conduct Authority, is reportedly considering opening an investigation into the alleged manipulation of WM/Reuters benchmark foreign-exchange rates, which are used to fix the value of trillions of dollars of investments. In a daily practice that has been continuing for at least a decade at major banks, traders front-run client orders and rig the rates by "pushing through trades before and during the 60-second windows when the benchmarks are set."

As expected, U.K. unemployment comes in at 7.8% in February-April, unchanged from November-January. The number of unemployed fell 5,000 to 2.51M. Inactivity rate +0.1 percentage point to 22.4%. Average weekly earnings excluding bonus in April +0.9% vs +0.8% prior and consensus of +0.7%. Claimant count -8,600 vs -11,800 and -5,000. Claimant count rate unchanged at 4.6%, as forecast. (PR)

First cut is the deepest:  MSCI has cut Greece's classification to emerging market from developed market, making the country first to suffer such a demotion. MSCI attributed the move to Greece not meeting requirements related to securities borrowing and lending facilities, short selling, transferability and stock-index size. MSCI's decision follows similar action from Russell Investments in March.

Eurozone industrial production +0.4% on month in April vs +0.9% in March and consensus of -0.2%. On year, output -0.6% vs -1.4% and -1.2%. The highest increases in April were in Ireland (+3%) and France (+2.3%) and the sharpest declines were in Finland (-5.1%), the Netherlands (-4.3%) and Portugal (-3.6%). (PR)

Illinois had to pay a premium on the sale of a $600M 10-year sales-tax backed bond yesterday, with the yield of 2.94% 0.75 percentage point higher than triple-A-rated debt on a benchmark scale. The auction came after Fitch and Moody's downgraded Illinois last week due to its inability to address its growing unfunded pension liabilities. Next week, the state legislature is scheduled to hold a special session over the crisis, while in two weeks, Illinois is due to auction a $1.25B bond

Boeing's (BA) 787 jet has been hit by yet another glitch, with All Nippon Airways scrapping an internal Japanese flight after one of the engines failed to start. The cancellation is the third this week after Dreamliner services were recently renewed following a four-month grounding. Still, at least it appears that the battery wasn't the problem.

Wages going the other way at CAT:  Caterpillar's (CAT) United Steelworkers employees have ratified a new six-year labor contract in what was described as a "very close" vote. The deal will freeze hourly wages for current staff for the lifetime of the agreement and pay new hires less. However, Caterpillar will hand out bonuses of $4,000 per worker in return for approving the contract, and it will pay veteran employees annual bonuses based on the performance of the company.

Amgen's (AMGN) blockbuster Enbrel drug for treating rheumatoid arthritis, which generated sales of $4.23B last year, is no more effective than a combination of three generic treatments, a study shows. While a regimen that includes Enbrel costs $25,000 a year per patient, the "triple therapy" costs just $1,000. The research didn't examine similar drugs from AbbVie (ABBV) or Johnson & Johnson (JNJ), although many doctors consider them to be equivalent to Enbrel. Despite the study, researchers feel that the branded treatments might be too well ensconced to be quickly replaced.

Institutional Shareholder Services has recommended that Sprint's (S) shareholders back SoftBank's (SFTBF.PK) latest $21.6B offer for 78% of the U.S. carrier. The proxy advisory firm also supported the Japanese company's $20.1B offer for 70% of Sprint. ISS ascribed its latest recommendation to the lack of other "firm competing bids" and improved terms. Dish (DISH) might have something to say about the first point, while Janco's Gerard Hallaren would disagree with the latter.

Vodafone (VOD) shares are -4.7% in London after its stock went ex-dividend today and following the company's confirmation that it is interested in acquiring Kabel Deutschland (KBDHY.OB). Vodafone has reportedly offered €10B for the German cable operator, whose shares are +7.4% in Frankfurt. That gives it a market cap of €7B.

    June 12th, 2013 at 5:58 am



 



Sign up here for a 30-day FREE trial of our PSW Report! (NO Credit Card required.)


See our disclaimer here.

 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Sabrient

Sector Detector: Will earnings season provide the next catalyst for stocks?

Courtesy of Sabrient Systems and Gradient Analytics

More unnerving conflicts around the globe have flared up, but as usual, U.S. equity investors have given it nary a yawn as they seem to have become pretty much numb to the steady stream of unwelcome news, particularly out of the Middle East. Now we enter the summer version of earnings season. Although sell-side expectations have been reduced from the previous lofty forecasts coming out of the dismal Q1 numbers, we’ll see if earnings reports can catalyze a renewed bullish march higher, or a long-feared bearish correction, or perhaps a resumption of the sideways-to-upward summer consolidation that we have seen so far.

Going into Q2 earnings season, projections are for the strongest in several years due to resurgent GDP growth, the highest level of stock buybacks since 2007, and a weak U.S. dollar (...



more from Sabrient

Insider Scoop

Benzinga's M&A Chatter for Thursday July 10, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday July 10, 2014:

ZF Friedrichshafen Confirms in Talks to Buy TRW Automotive

The Offer:
Shares of TRW Automotive (NYSE: TRW) soared Thursday, on a report from Bloomberg that the company could be acquired for as much as $12 billion by Germany's ZF Friedrichshafen AG.

TRW later confirmed it had been approached by a potential buyer, followed by Friedrichshaf...



http://www.insidercow.com/ more from Insider

Phil's Favorites

Fed Officials Trying to Warn Bond Markets

Fed Officials Trying to Warn Bond Markets

Courtesy of EconMatters

The Purpose of Complacency Talk   The Fed officials have been coming out in speeches the last couple of weeks with rhetoric about ‘complacency’ and other such code words for chasing risk ahead of what the Federal Reserve knows is going to be an abrupt change in monetary policy over the next six months.  
  The Fed is concerned because they know they want an orderly transition in markets and not causing major dislocations in markets by massive selloffs. However...

more from Ilene

Zero Hedge

Meanwhile, In Argentina: Riot Police Unleash Tear Gas & Water Cannons In Buenos Aires - Live Feed

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

With the nation teetering on the brink of default amid major inflation pressures at home and growing poverty (and Kirchner facing pressure into next year's election), today's loss in the FIFA World Cup final appears to have lit the blue touch paper. As RT reports, police used tear gas and water cannons to disperse angry fans in Buenos Aires. Following the mass gathering around the Obelisk during the game, fans clashed with riot police as the loss sunk in. There are no reports of civilian injuries but 8 police were hurt. Rio has also seen violence between Argentina fans and others (and Brazil's Rousseff has issued a calming stat...



more from Tyler

Chart School

Gauging Investor Sentiment with Twitter: Weekly Update

Courtesy of Doug Short.

Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of Advisor Perspectives.

The Downside Hedge sentiment indicators for the S&P 500 Index (SPX) from both Twitter and StockTwits issued consolidation warnings on Friday. The rally from 1900 to 1985 on SPX has been met with skepticism from traders on StockTwits and Twitter. As the rally progressed smoothed sentiment steadily decreased creating a negative divergence from price lasting two months. At the close on Friday smoothed sentiment broke sharply below a confirming uptrend line that had been in place for over three months. The break of the uptrend line after a negative divergence creates the warning.

Please note this isn’t a prediction of a long term top, merely warning that the market has lost suppor...



more from Chart School

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Stock World Weekly

Stock World Weekly

Newsletter writrers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

The latest Stock World Weekly is now ready for your viewing. Please sign in with your PSW user name and password. (A free trial is also available here.)

 

#451625918 / gettyimages.com

 

...

more from SWW

Market Shadows

Danger: Falling Prices

Danger: Falling Prices

By Dr. Paul Price of Market Shadows

 

We tried holding up stock prices but couldn’t get the job done. Market Shadows’ Virtual Value Portfolio dipped by 2% during the week but still holds on to a market-beating 8.45% gain YTD. There was no escaping the downdraft after a major Portuguese bank failed. Of all the triggers for a large selloff, I’d guess the Portuguese bank failure was pretty far down most people's list of "things to worry about." 

All three major indices gave up some ground with the Nasdaq composite taking the hardest hi...



more from Paul

Option Review

Options Active On Amazon.Com

Options on Amazon.com, Inc. (Ticker: AMZN) are seeing heavy volume on the final trading session of the week amid strong gains in the price of the stock, which is currently up more than 4.0% on the day at $342.09 and the highest level since April. At last check, more than 127,000 options contracts have changed hands on Amazon or twice the stock’s average daily options volume of around 63,100 contracts. Call options are more active than puts as of the time of this writing, with the call/put ratio hovering near 1.33 just before midday in New York. The bulk of the volume is in the 11Jul’14 weekly options currently in their final day of trading prior to expiration, and in the 18Jul’14 expiry calls and puts. Amazon.com reports second-quarter earnings after the close of trading on July 24th.

...

more from Caitlin

OpTrader

Swing trading portfolio - week of July 7th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here...



more from OpTrader

Digital Currencies

Bitcoin Vs Gold - The Infographic

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

While Marc Faber has said "I will never sell my gold," he also noted "I like the idea of Bitcoin," and the battle between the 'alternative currencies' continues. The following infographic provides a succinct illustration of the similarities and differences between gold and bitcoin.

Please include attribution to www.jmbullion.com with this graphic.

...

more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>